Our post-marketing Business Units, namely Innovative/Brand, Generics, Hybrids, Biosimilars and Vaccines provide secure safety monitoring of first time exposure in the wider population and outside of the controlled conditions of clinical settings.

Clinical safety is served by our Clinical Safety Business Unit which has assisted 300 clinical trials over the last 15 years.

We pride ourselves on managing diverse safety cases in terms of volume and complexity efficiently and accelerating your peri- and post-marketing milestones.

At PrimeVigilance we offer tailored pharmacovigilance solutions for medicines for older patients, pediatric medicines and medical devices & combination products.